Novel drugs that target the metabolic reprogramming in renal cell cancer

Johannes C. van der Mijn, David J. Panka, Andrew K. Geissler, Henk. M. Verheul, James W. Mier

Research output: Contribution to journal › Article › Academic › peer-review

Keywords

@article{4b4b41b912d84c2bbe7cc0546a8b3671,

title = "Novel drugs that target the metabolic reprogramming in renal cell cancer",

keywords = "Glutamine, HIF, MYC, Renal cell cancer, Warburg",

author = "{van der Mijn}, {Johannes C.} and Panka, {David J.} and Geissler, {Andrew K.} and Verheul, {Henk. M.} and Mier, {James W.}",

year = "2016",

month = jul,

day = "13",

doi = "https://doi.org/10.1186/s40170-016-0154-8",

language = "English",

volume = "4",

journal = "CANCER & METABOLISM",

issn = "2049-3002",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Novel drugs that target the metabolic reprogramming in renal cell cancer

AU - van der Mijn, Johannes C.

AU - Panka, David J.

AU - Geissler, Andrew K.

AU - Verheul, Henk. M.

AU - Mier, James W.

PY - 2016/7/13

Y1 - 2016/7/13

KW - Glutamine

KW - HIF

KW - MYC

KW - Renal cell cancer

KW - Warburg

U2 - https://doi.org/10.1186/s40170-016-0154-8

DO - https://doi.org/10.1186/s40170-016-0154-8

M3 - Article

C2 - 27418963

SN - 2049-3002

VL - 4

JO - CANCER & METABOLISM

JF - CANCER & METABOLISM

ER -